Bifidobacterium: A promising coadjuvant for colorectal carcinoma

dc.contributor.authorYegin, Zeynep
dc.contributor.authorYildirim, Seval Cing
dc.date.accessioned2025-03-23T18:54:43Z
dc.date.available2025-03-23T18:54:43Z
dc.date.issued2024
dc.departmentSinop Üniversitesi
dc.description.abstractColorectal cancer prevalence has rapidly increased due to dietary changes to Western style. The regulation of the gut microbiota may serve as a promising approach in colorectal cancer management. The dysbiosis of the gut microbiome affects cancer development because of its roles in inflammation and genotoxicity. Cell culture studies, animal studies, and some novel clinical studies refer to the therapeutic potential of Bifidobacterium.
dc.description.abstractBati tarzi beslenme degisiklikleri nedeniyle kolorektal kanser prevalansi hizla artis göstermistir. Bagirsak mikrobiyotasinin düzenlenmesi kolorektal kanser tedavisinde ümit verici bir yaklasim olarak hizmet edebilir. Bagirsak mikrobiyomunun disbiyozu, inflamasyon ve genotoksisitedeki rollerinden dolayi kanser gelisimini etkilemektedir. Hücre kültürü çalismalari, hayvan çalismalari ve bazi yeni klinik çalismalar Bifidobakterinin terapötik potansiyeline isaret etmektedir.
dc.identifier.doi10.58961/hmj.1508458
dc.identifier.doihttps://doi.org/10.58961/hmj.1508458
dc.identifier.endpage160
dc.identifier.issn2791-9935
dc.identifier.issue3
dc.identifier.startpage156
dc.identifier.urihttps://hdl.handle.net/11486/2314
dc.identifier.volume4
dc.language.isoen
dc.publisherBandirma Onyedi Eylul University
dc.relation.ispartofHipokrat Tip Dergisi
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20250323
dc.subjectBifidobacterium
dc.subjectcolorectal cancer
dc.subjectapoptosis
dc.subjectprobiotics
dc.titleBifidobacterium: A promising coadjuvant for colorectal carcinoma
dc.title.alternativeBifidobakteri: Kolorektal karsinom için umut vadedici bir koadjuvan
dc.typeOther

Dosyalar